Brand / product
Convidecia
COVID-19 vaccine (recombinant adenovirus type 5 vector) · ≥5.0 × 10^10 viral particles/0.5 mL
Current listed pricePKR 5,687.56Effective 2025-08-19
Product details
- Generic
- COVID-19 vaccine (recombinant adenovirus type 5 vector)
- Therapeutic class
- —
- ATC
- —
- Strength
- ≥5.0 × 10^10 viral particles/0.5 mL
- Dosage form
- Injection
- Pack
- 01 Dose (Vial)
- Registration no.
- 107886
- Verification
- 2026-08-07
Manufacturer
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Traceability
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 5,687.56 | 2025-08-19 | 2026-08-07 | DRAP PharmaPrice Index | Current |
Same generic
Alternative listed brands
Price note: MedInfoBase displays source-listed prices where available. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.